Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Role of nutrients in neurological disorders / / edited Senthilkumar Rajagopal [and three others]
| Role of nutrients in neurological disorders / / edited Senthilkumar Rajagopal [and three others] |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (389 pages) |
| Disciplina | 745.05 |
| Collana | Nutritional Neurosciences |
| Soggetto topico | Neurosciences |
| ISBN |
981-16-8158-9
981-16-8157-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword by Dr. Sesikeran Boindala -- Foreword by Dr. Undurti N. Das -- Foreword by Dr. N. R. Jagannathan -- Preface -- Contents -- About the Editors -- Part I: Neurological Disorders from Background to Interplay of Genetic, Epigenetic and Environmental Risk Factors -- Chapter 1: Phytonutrients in Neurological Disorders -- 1.1 Introduction -- 1.1.1 Plant Based Medicines for OCD -- 1.1.1.1 Benincasa hispida (Thunb.) Cogn -- 1.1.1.2 Cannabis sativa L. -- 1.1.1.3 Citrus aurantium L (Bitter Orange) -- 1.1.1.4 Clitoria ternatea L -- 1.1.1.5 Colocasia esculenta (L.) Schott -- 1.1.1.6 Crocus sativus L. -- 1.1.1.7 Curcumin -- 1.1.1.8 Echium amoenum. Fisch -- 1.1.1.9 Hypericum perforatum L -- 1.1.1.10 Lagenaria siceraria (Molina) -- 1.1.1.11 Pyrus communis -- 1.1.1.12 Milk Thistle (Silybum marianum) -- 1.1.1.13 Tabernaemontana divaricata (L). -- 1.1.1.14 Withania somnifera (L). Dunal -- 1.1.1.15 Valeriana officinalis L. -- 1.1.1.16 Cassia auriculata L. -- 1.2 Summary and Future Perspectives -- References -- Chapter 2: Psychobiotics in Health, Longevity, and Neurological Disorders -- 2.1 Psychobiotics: A New Class of Psychotropic -- 2.2 Psychobiotics in Brain Health -- 2.3 Psychobiotics in Aging and Longevity -- 2.4 Psychobiotics in Neurodevelopmental Disorders -- 2.4.1 Autism Spectrum Disorder (ASD) -- 2.4.2 Attention-Deficit/Hyperactivity Disorder (ADHD) -- 2.5 Psychobiotics in Neurodegenerative Diseases -- 2.5.1 Alzheimer´s Disease (AD) -- 2.5.2 Parkinson´s Disease (PD) -- 2.6 Conclusions -- References -- Chapter 3: Nutritional, Dietary, and Lifestyle Approaches for Prevention and Management of Alzheimer´s Disease -- 3.1 Introduction -- 3.1.1 Risk Factors -- 3.2 Role of Nutrients in Prevention and Management of Alzheimer´s Disease -- 3.2.1 Antioxidants -- 3.2.2 Dietary Fat -- 3.2.3 Saturated Fat and Trans Fat.
3.2.4 Monounsaturated fatty acid (MUFA) -- 3.2.5 Polyunsaturated Fatty Acid (PUFA) -- 3.2.6 Carbohydrate -- 3.2.7 Vitamins -- 3.2.8 Vitamin B Complex -- 3.2.9 Vitamin C -- 3.2.10 Vitamin E -- 3.2.11 Vitamin D -- 3.2.12 Vitamin A -- 3.3 Minerals -- 3.3.1 Selenium -- 3.3.2 Copper -- 3.3.3 Iron -- 3.3.4 Zinc -- 3.3.5 Aluminum -- 3.3.6 Polyphenols -- 3.4 Role of Diet in Prevention and Management of Alzheimer´s Disease -- 3.4.1 Role of Food Components in the Prevention and Management of Alzheimer´s Disease -- 3.4.1.1 Fish -- 3.4.1.2 Fruits and Vegetables -- 3.4.1.3 Dairy and Dairy Products -- 3.4.1.4 Tea and Coffee -- 3.4.1.5 Alcohol -- 3.4.2 Role of Dietary Pattern and Diet in Prevention and Management of Alzheimer´s Disease -- 3.4.2.1 Healthy Dietary Pattern -- 3.4.2.2 Western Dietary Pattern -- 3.4.2.3 Mediterranean Diet -- 3.4.2.4 DASH Diet -- 3.5 General Dietary and Lifestyle Approaches for Prevention and Management of Alzheimer´s Disease -- 3.6 Perspective -- References -- Chapter 4: Qualitative and Analytical Treatment of Nonlinear Dynamical Systems in Neurological Diseases -- 4.1 Introduction -- 4.2 Mathematical Methods -- 4.2.1 Basic Concepts -- 4.2.2 Linearization and Solving Linear Systems of ODEs -- 4.2.3 Stability of Solutions of ODEs -- 4.2.4 Lyapunov Functions -- 4.2.5 Matrix Differential Equations -- 4.3 Approximate Analytical Solutions -- 4.3.1 Non perturbation Techniques -- 4.3.2 Homotopy Analysis Method (HAM) -- 4.4 Numerical Methods -- 4.4.1 Euler´s method -- 4.4.2 Runge-Kutta Method -- 4.4.3 Runge-Kutta Butcher method -- References -- Chapter 5: Impact of a Psychological Follow-Up of Diabetics in the Management of Diabetes in Morocco -- 5.1 Introduction -- 5.2 Materials and Methods -- 5.2.1 Population -- 5.2.2 Data Collection -- 5.2.2.1 Anthropometric Measurements -- 5.2.2.2 Psychological Intervention -- 5.3 Results -- 5.4 Discussion. 5.5 Conclusion -- References -- Chapter 6: Neuroprotective and Anxiolytic Effects of Date Seeds Phenolic Compounds in Nicotinamide-Streptozotocin-Induced Type... -- 6.1 Introduction -- 6.2 Materials and Methods -- 6.2.1 Extraction of Phenolic Compounds from Date Seeds -- 6.2.2 Total Phenolic Contents of Date Seed Extract -- 6.2.3 Effect of Date Seed Phenolic Compounds in NA-STZ Diabetic Rat -- 6.2.3.1 Animals -- 6.2.3.2 Acute Toxicity -- 6.2.3.3 Experimental Diabetes Induction and Study Design -- 6.2.3.4 Anxiety-Related Behavior Tests -- Black-White Box Test -- Open Field Test -- Novelty Suppressed Feeding Test -- Elevated Plus Maze Test -- 6.2.3.5 Biochemical Assays -- Tissue Preparation and Protein Assay -- Lipid Peroxidation Assay -- Tumor Necrosis Factor-Alpha Estimation -- 6.2.4 Data Analysis -- 6.3 Results -- 6.3.1 Total Phenolic Content (TPC) and Acute Oral Toxicity of Date Seeds Extract (DSE) -- 6.3.2 Changes in Fasting Blood Glucose, Body Weight, and Food Intake in Normal and NA-STZ Diabetic Rat -- 6.3.3 Lipid Peroxidation Level in Hippocampus and Prefrontal Cortex in Normal and NA-STZ Diabetic Rat -- 6.3.4 Level of Tumor Necrosis Factor-α in the Prefrontal Cortex and Hippocampus in Normal and Diabetic Rat -- 6.3.5 Measures of Anxiety in Normal and NA-STZ Diabetic Rat -- 6.4 Discussion -- References -- Chapter 7: Role of Nutrition in Pathogenesis of Neurological Disorders -- 7.1 Introduction -- 7.2 What Are Neurological Disorders? -- 7.2.1 What Causes a Neurological Disorder? -- 7.2.2 Classification of Neurological Disorders -- 7.2.3 Neurological Symptoms -- 7.2.3.1 What Are the Signs? -- 7.3 Nutrition and Health -- 7.3.1 Etiology -- 7.3.2 Risk Factors -- 7.4 Neurologic Diseases Seen in the Setting of Alcoholism -- 7.4.1 Wernicke´s Encephalopathy -- 7.4.2 Fetal Alcohol Syndrome -- 7.4.3 Delirium Tremens -- 7.4.4 Alcoholic Neuropathy. 7.4.5 Alcoholic Cerebellar Degeneration -- 7.4.6 Marchiafava-Bignami Disease -- 7.4.7 Alcohol and Epilepsy -- 7.5 Neuro-Disorder Management -- 7.5.1 Dietary Intervention for Improved Cognitive Abilities -- 7.5.1.1 Omega-3 Fatty Acids -- 7.5.1.2 Dietary Polyphenols -- 7.5.1.3 Foods to Be Avoid -- 7.6 Conclusion -- References -- Part II: Specific Food and Nutritional Qualities on Neurological Disorders -- Chapter 8: Best Foods for Repair of Brain Damage -- 8.1 Introduction -- 8.1.1 Brain Damage and Its Types -- 8.1.2 Causes of Brain Damage -- 8.1.3 Symptoms of Brain Damage -- 8.2 Obsessive Compulsive Disorder (OCD) -- 8.3 Treating OCD and Brain Damage -- 8.3.1 Antidepressant Drugs -- 8.3.2 Rehabilitation Therapies -- 8.3.3 Psychological Support -- 8.4 Nutrition for Brain Damage -- 8.4.1 Essential Vitamins -- 8.4.2 Essential Minerals -- 8.5 Best Food for Brain Injury -- 8.5.1 Omega-3 Fatty Acids -- 8.5.2 Dark Chocolate -- 8.5.3 Berries -- 8.5.4 Meat -- 8.5.5 Turmeric Root or Powder -- 8.5.6 Eggs and Avocados -- 8.5.7 Foods to Avoid During Brain Injury -- 8.6 Role of Exercise During Recovery -- 8.7 Combined Effects of Diet and Exercise -- 8.8 Conclusion -- References -- Chapter 9: Role of Micronutrients in Neurological Development -- 9.1 Introduction -- 9.2 Role of Major Micronutrients in Neurological Disorders -- 9.2.1 Vitamin-A (Retinoid Acid) -- 9.2.2 Vitamin B1 (Thiamine) -- 9.2.3 Vitamin B2 (Riboflavin) -- 9.2.4 Vitamin B3 (Niacin) -- 9.2.5 Vitamin B6 (Pyridoxine) -- 9.2.6 Vitamin B12 (Cobalamin) -- 9.2.7 Vitamin D -- 9.2.8 Vitamin E -- 9.2.9 Vitamin C -- 9.2.10 Folic Acid -- 9.2.11 Copper -- 9.2.12 Iodine -- 9.2.13 Zinc -- 9.2.14 Magnesium -- 9.2.15 Selenium -- 9.2.16 Iron -- 9.2.17 ω-3 LCPUFA -- 9.3 Combination of Micronutrients/Micronutrient Mixtures Used to Combat Neurological Disorders -- 9.3.1 EMPowerplus -- 9.3.2 SeroPlus -- 9.3.3 Amoryn. 9.3.4 Berocca -- 9.4 Role of Toxic Metals in Neurodegeneration -- 9.4.1 Copper (Cu) -- 9.4.2 Lead (Pb) -- 9.4.3 Mercury (Hg) -- 9.4.4 Cadmium (Cd) -- 9.5 Conclusion -- References -- Chapter 10: Algae as a Potential Vegetative Source of PUFA for the Prevention of Neurological Disorders -- 10.1 Introduction -- 10.2 Importance of PUFA -- 10.3 Available Sources of PUFA -- 10.4 Algae as a Source of PUFA -- 10.5 Strategies for Enhancement of Omega-3 Fatty Acids in Algae -- 10.5.1 Light -- 10.5.2 Temperature -- 10.5.3 Nutrients -- 10.6 Strategies -- 10.7 Experiments Conducted on Neurological Disorders -- 10.8 Neuro-Inflammation -- 10.9 Neurotoxins from Cyanobacteria -- 10.10 Conclusion -- References -- Chapter 11: Natural Foods for Suppressing Dementia -- 11.1 Introduction -- 11.2 Types -- 11.2.1 Alzheimer´s Disease -- 11.2.2 Vascular Dementia -- 11.2.3 Mixed Dementia -- 11.2.4 Dementia with Lewy Bodies -- 11.2.5 Front Temporal Dementia (Including Pick´s Disease) -- 11.3 Signs and Symptoms -- 11.3.1 Early Phase -- 11.3.2 Middle Phase -- 11.3.3 Late Phase -- 11.4 Stages of Disease -- 11.5 Diagnosis -- 11.5.1 Preliminary Testing -- 11.5.2 Cognitive Testing -- 11.5.3 Laboratory Tests -- 11.5.4 Imaging Scans -- 11.6 Nutritional Treatment -- 11.6.1 Polyphenols -- 11.6.2 Resveratrol -- 11.6.3 Olive Oil -- 11.6.4 Fruit and Vegetables -- 11.6.5 Insulin Signaling and Calorie Restriction (CR) Effect -- 11.6.6 Ketogenic Diet and Brain Function -- 11.6.7 Traditional Medicines and Diets -- 11.6.8 Ayurvedic Medicine -- 11.7 Supplements -- 11.7.1 Vitamin B12 and Folic Acid -- 11.7.2 Vitamin B1 -- 11.7.3 Niacin -- 11.7.4 Polyunsaturated Fatty Acids (PuFa) -- 11.8 Conclusion -- References -- Chapter 12: Nutrients´ Role in the Treatment of Parkinson´s and Alzheimer´s Diseases -- 12.1 Introduction -- 12.2 Alzheimer´s Disease (AD) -- 12.2.1 Complications of AD. 12.2.2 Polyunsaturated Fatty Acids (PUFAs). |
| Record Nr. | UNINA-9910743344403321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Zebrafish: A Model for Marine Peptide Based Drug Screening [[electronic resource] /] / by Saravanan Ramachandran, Senthilkumar Rajagopal
| Zebrafish: A Model for Marine Peptide Based Drug Screening [[electronic resource] /] / by Saravanan Ramachandran, Senthilkumar Rajagopal |
| Autore | Ramachandran Saravanan |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XI, 73 p. 39 illus., 29 illus. in color.) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Animal models in research Human physiology Cancer research Pharmacy Pharmacology/Toxicology Animal Models Human Physiology Cancer Research Drug Safety and Pharmacovigilance |
| ISBN | 981-13-7844-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Biomedical importance of marine peptides/toxins -- Chapter 2. Toxicity of peptides in Zebrafish embryos -- Chapter 3. Teratogenic activity of toxins in Zebrafish model -- Chapter 4. Anticancer properties marine peptides/toxins using Zebrafish model -- Chapter 5. Protective effect of marine peptides/toxins in CVD using Zebrafish model. |
| Record Nr. | UNINA-9910350356203321 |
Ramachandran Saravanan
|
||
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||